Precigen: Funding, Investors & Team (Oct 2026)
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Precigen has raised $109M across 2 funding rounds on record, the most recent an undisclosed round of $79.0M announced in Dec 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Precigen Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Precigen Funding Rounds
Precigen raised $30.0M in an undisclosed round announced in Aug 2024.
4 months later, an undisclosed round of $79.0M was announced in Dec 2024.
Precigen Founders and Leadership Team
No contact details are on record for this team yet.
Precigen Funding Compared to Other Biotechnology Startups
Precigen's latest round of $79.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Precigen in Biotechnology and Germantown
Companies Similar to Precigen
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Precigen Funding FAQs
What does Precigen do?
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
How much funding has Precigen raised?
Precigen has raised $109M across 2 rounds on record. The most recent is an undisclosed round of $79.0M announced in Dec 2024.
When did Precigen last raise funding?
Precigen's most recent funding round on record is an undisclosed round of $79.0M, announced in Dec 2024.
Who founded Precigen?
FundedIQ lists Thomas D Reed (Founder), Thomas D. Reed (Founder) at Precigen.
Where is Precigen headquartered?
Precigen is based in Germantown, Maryland, United States.
How many employees does Precigen have?
Precigen is in the 101-250 employee band.
How does Precigen's funding compare to other Biotechnology startups?
Precigen's latest round of $79.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Precigen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Precigen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.